** Gene sequencing equipment maker Illumina's ILMN.O shares fall 2.62% to $82 premarket
** China bans ILMN's gene sequencers, just minutes after U.S. President Donald Trump's additional 10% tariff took effect
** Beijing had put Illumina on its "unreliable entity" list in February
** Sales in China account for about 7% of the company's revenue
** Stock has fallen 37% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。